APA (7th ed.) Citation

Neubauer, A., Voss, P., Gmeiner, A., & Neubauer, G. (2013). Amnog Benefit Assessment: Time Delay of Market Access for Pharmaceuticals in Germany? Value in health, 16(7), A475. https://doi.org/10.1016/j.jval.2013.08.885

Chicago Style (17th ed.) Citation

Neubauer, A.S, P. Voss, A. Gmeiner, and G. Neubauer. "Amnog Benefit Assessment: Time Delay of Market Access for Pharmaceuticals in Germany?" Value in Health 16, no. 7 (2013): A475. https://doi.org/10.1016/j.jval.2013.08.885.

MLA (9th ed.) Citation

Neubauer, A.S, et al. "Amnog Benefit Assessment: Time Delay of Market Access for Pharmaceuticals in Germany?" Value in Health, vol. 16, no. 7, 2013, p. A475, https://doi.org/10.1016/j.jval.2013.08.885.